Glycoengineering HIV-1 Env creates ‘supercharged’ and ‘hybrid’ glycans to increase neutralizing antibody potency, breadth and saturation
Author(s):
Ema T. Crooks, Samantha L. Grimley, Michelle Cully, Keiko Osawa, Gillian Dekkers, Kevin Saunders, Sebastian Rämisch, Sergey Menis, William R. Schief, Nicole Doria-Rose, Barton Haynes, Ben Murrell, Evan Mitchel Cale, Amarendra Pegu, John R. Mascola, Gestur Vidarsson, James M. Binley
Details:
PLoS Pathogens, Volume 14, Issue 5, 2018-05-01, Article number e1007024
Article Link: Click here
Affiliations:
- Universiteit van Amsterdam
- Duke University Medical Center
- Scripps Research Institute
- National Institute of Allergy and Infectious Diseases (NIAID)
- Department of Medicine
- Department of Microbiology & Immunology
- San Diego Biomedical Research Institute
- Ragon Institute

